Qianlieping capsule plus alpha-blocker for chronic non-bacterial prostatitis: analysis of 220 cases / 中华男科学杂志
National Journal of Andrology
; (12): 856-858, 2012.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-286410
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the clinical effects of Qianlieping Capsule combined with alpha-receptor blocker tamsulosin on chronic non-bacterial prostatitis (CNBP).</p><p><b>METHODS</b>We assigned 220 CNBP patients to three groups to receive oral Qianlieping Capsule (2.0 g tid) plus alpha-receptor blocker tamsulosin (0.2 mg qd) (n = 98), Qianlieping Capsule alone at 2.0 g tid (n = 66), and tamsulosin alone at 0.2 mg qd (n = 56) , respectively. After 6 weeks of medication, we assessed the therapeutic effects according to the NIH-CPSI scores and the number of small particles of lecithin (SPL) in the prostatic fluid after treatment.</p><p><b>RESULTS</b>Qianlieping Capsule alone increased the number of SPL by 46.9% and reduced the NIH-CPSI score by 24.4%. Combination of Qianlieping and tamsulosin more significantly increased the number of SPL (61.4%) and decreased the NIH-CPSI score (42.3%) than tamsulosin alone (33.7% and 28.6%) (P < 0.01).</p><p><b>CONCLUSION</b>Qianlieping Capsule chronic is effective for chronic non-bacterial prostatitis, and the combination of Qianlieping Capsule with tamsulosin produces even better effect than tamsulosin alone.</p>
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Prostatite
/
Sulfonamidas
/
Cápsulas
/
Medicamentos de Ervas Chinesas
/
Doença Crônica
/
Resultado do Tratamento
/
Antagonistas Adrenérgicos alfa
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Fitoterapia
Limite:
Adolescente
/
Adulto
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
National Journal of Andrology
Ano de publicação:
2012
Tipo de documento:
Artigo